Kura Oncology (KURA) Shares Outstanding (Weighted Average) (2010 - 2026)
Kura Oncology (KURA) reported Shares Outstanding (Weighted Average) of $88.6 million for Q1 2026, up 1210.9% year-over-year from $6.8 million in Q1 2025, and up 1.07% on a QoQ basis from $87.7 million in Q4 2025.
Kura Oncology (KURA) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $88.6 million in Q1 2026.
- Quarterly Shares Outstanding (Weighted Average) rose 1210.9% year-over-year to $88.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $88.6 million (up 1210.9% YoY) and the FY2025 annual result came in at $87.7 million, up 1197.09% from the prior year.
- Shares Outstanding (Weighted Average) advanced to $88.6 million in Q1 2026 per KURA's latest filing, from $87.7 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $88.6 million in Q1 2026 and bottomed at $840585.0 in Q3 2025.
- The 5-year median for Shares Outstanding (Weighted Average) is $69.1 million (2023), against an average of $63.5 million.
- The widest annual swing landed in 2024, when Shares Outstanding (Weighted Average) sank 96.97%; it then jumped 1210.9% in 2026.
- Tracing KURA's Shares Outstanding (Weighted Average) over 5 years: stood at $67.0 million in 2022, then advanced by 9.31% to $73.2 million in 2023, then climbed by 17.66% to $86.2 million in 2024, then increased by 1.76% to $87.7 million in 2025, then climbed by 1.07% to $88.6 million in 2026.
- Per Business Quant, the three latest KURA Shares Outstanding (Weighted Average) figures stand at $88.6 million (Q1 2026), $87.7 million (Q4 2025), and $840585.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.04 Bn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 88.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.61 Mn |
| Dec 31, 2025 | 87.68 Mn |
| Sep 30, 2025 | 840,585.00 |
| Jun 30, 2025 | 87.59 Mn |
| Mar 31, 2025 | 6.76 Mn |
| Dec 31, 2024 | 86.16 Mn |
| Sep 30, 2024 | 2.17 Mn |
| Jun 30, 2024 | 86.64 Mn |
| Mar 31, 2024 | 83.91 Mn |
| Dec 31, 2023 | 73.23 Mn |
| Sep 30, 2023 | 71.85 Mn |
| Jun 30, 2023 | 69.10 Mn |
| Mar 31, 2023 | 68.40 Mn |
| Dec 31, 2022 | 66.99 Mn |
| Sep 30, 2022 | 66.72 Mn |
| Jun 30, 2022 | 66.67 Mn |
| Mar 31, 2022 | 66.61 Mn |
| Dec 31, 2021 | 66.35 Mn |
| Sep 30, 2021 | 66.29 Mn |
| Jun 30, 2021 | 66.25 Mn |
| Mar 31, 2021 | 66.22 Mn |
| Dec 31, 2020 | 53.08 Mn |
| Sep 30, 2020 | 56.41 Mn |
| Jun 30, 2020 | 48.52 Mn |
| Mar 31, 2020 | 45.41 Mn |
| Dec 31, 2019 | 41.95 Mn |
| Sep 30, 2019 | 45.24 Mn |
| Jun 30, 2019 | 38.93 Mn |
| Mar 31, 2019 | 38.17 Mn |
| Dec 31, 2018 | 35.19 Mn |
| Sep 30, 2018 | 37.79 Mn |
| Jun 30, 2018 | 32.97 Mn |
| Mar 31, 2018 | 31.83 Mn |
| Dec 31, 2017 | 23.24 Mn |
| Sep 30, 2017 | 21.22 Mn |
| Jun 30, 2017 | 19.63 Mn |
| Mar 31, 2017 | 19.46 Mn |
| Dec 31, 2016 | 18.70 Mn |
| Sep 30, 2016 | 18.55 Mn |
| Jun 30, 2016 | 18.55 Mn |
| Mar 31, 2016 | 18.25 Mn |
| Dec 31, 2015 | 9.93 Mn |
| Sep 30, 2015 | 10.72 Mn |
| Jun 30, 2015 | 6.82 Mn |
| Mar 31, 2015 | 3.18 Mn |
| Dec 31, 2014 | 141,000.00 |
| Sep 30, 2014 | 2,000.00 |
| Jun 30, 2014 | 4.94 Mn |
| Mar 31, 2014 | 4.94 Mn |
| Dec 31, 2013 | 5.00 Mn |
| Sep 30, 2013 | 5.00 Mn |
| Jun 30, 2013 | 5.00 Mn |
| Mar 31, 2013 | 5.00 Mn |
| Dec 31, 2012 | 5.00 Mn |
| Sep 30, 2012 | 5.00 Mn |
| Jun 30, 2012 | 5.00 Mn |
| Mar 31, 2012 | 5.00 Mn |
| Dec 31, 2011 | 5.00 Mn |
| Sep 30, 2011 | 5.00 Mn |
| Jun 30, 2011 | 5.00 Mn |
| Mar 31, 2011 | 5.00 Mn |
| Dec 31, 2010 | 5.00 Mn |
| Sep 30, 2010 | 5.00 Mn |